Latest Regulatory Approval News

Mineral Resources Limited has released its inaugural Mineral Resources and Ore Reserves statements for the Pilbara Hub, revealing a substantial 161 million tonnes resource and 50.7 million tonnes reserve at robust iron grades. The inclusion of the Lamb Creek deposit promises to extend the hub’s production profile by five years, pending approvals.

Midas Minerals has secured a crucial licence transfer for its Otavi Copper Project acquisition in Namibia, moving closer to drilling plans slated for late 2025. The company now awaits final regulatory approval and capital raising to complete the deal.

Coda Minerals reports a metallurgical breakthrough at its Elizabeth Creek project, significantly increasing copper and silver recoveries while reducing costs, leading to a substantial uplift in project economics. The simplified flowsheet excludes cobalt from the base case, lowering risk and positioning cobalt as future upside.

Yari Minerals has increased its inferred coal resource at the Rolleston South Coal Project by 26% to approximately 190 million tonnes, leveraging new data from coal seam gas wells. The company plans a drilling campaign to upgrade resource classification and explore semi-soft coking coal potential.

Centuria Industrial REIT (ASX – CIP) has announced a $300 million exchangeable notes offering due 2030, alongside a concurrent repurchase of existing notes, aiming to lower debt costs and extend maturity. The move underscores CIP’s strategic capital management amid a complex market environment.

Nova Eye Medical has reported a record A$29.3 million in FY25 revenue, driven by sustained US growth and operational improvements, setting the stage for breakeven EBITDA in the first half of FY26.

Optiscan Imaging Limited has launched a $17.75 million fully underwritten entitlement offer to fund clinical trials, regulatory approvals, and product development. Peters Investments underwrites the offer, potentially increasing its stake to nearly 39%.

Cedar Woods Properties has updated its Dividend Reinvestment Plan default to cash payment and announced a fully franked 19-cent dividend for the half-year ending June 2025.

Optiscan Imaging Ltd has launched a fully underwritten $17.75 million entitlement offer to fund clinical trials and regulatory clearances for its medical devices, marking a pivotal step in its transition to a commercial medical device manufacturer.

Critical Metals Corp has signed a multi-year letter of intent to supply rare earth concentrate from its Greenland project to Ucore Rare Metals’ US Department of Defense-backed processing facility, aiming to build a China-independent supply chain.

Karoon Energy’s 2025 half-year results reveal a 4% rise in production alongside a significant drop in profits, driven by lower oil prices and increased costs. The company advances key projects and completes its Baúna FPSO acquisition, setting the stage for future growth.

NH3 Clean Energy has launched the FEED phase for its WAH2 clean ammonia project, advancing environmental approvals and commercial negotiations with potential strategic partners.